We are live on
!
Find out more
EFM
E Fund Management Portfolio holdings
AUM
$3.37B
This Fund
S&P 500
This Quarter
Est. Return
+14.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$4.5M
(+0.21%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-8.52%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
429
New
31
Increased
83
Reduced
267
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
abrdn Physical Gold Shares ETF
SGOL
|
+$19.9M |
| 2 |
iShares Gold Trust
IAU
|
+$19.7M |
| 3 |
SPDR Gold MiniShares Trust
GLDM
|
+$19.5M |
| 4 |
SPDR Gold Trust
GLD
|
+$19.5M |
| 5 |
Invesco DB Oil Fund
DBO
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KE Holdings
BEKE
|
+$70.4M |
| 2 |
Futu Holdings
FUTU
|
+$30.9M |
| 3 |
Apple
AAPL
|
+$18.5M |
| 4 |
Microsoft
MSFT
|
+$11.9M |
| 5 |
Applied Materials
AMAT
|
+$9.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.87% |
| 2 | Consumer Discretionary | 23.94% |
| 3 | Communication Services | 11.36% |
| 4 | Healthcare | 5.11% |
| 5 | Financials | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
301
DELISTED
Hologic
HOLX
| $303K | 0.01% |
4,646
-851
| -15% | -$51K |
|
302
BioCryst Pharmaceuticals
BCRX
$2.37B
| $301K | 0.01% |
33,592
+9,918
| +42% | +$92.4K |
|
303
Align Technology
ALGN
$12B
| $301K | 0.01% |
1,588
-366
| -19% | -$64.7K |
|
304
Solventum
SOLV
$13.5B
| $300K | 0.01% |
3,960
-431
| -10% | -$30.5K |
|
305
Revvity
RVTY
$12.3B
| $300K | 0.01% |
3,104
+108
| +4% | +$10.2K |
|
306
Henry Schein
HSIC
$9.74B
| $299K | 0.01% |
4,095
-501
| -11% | -$34.5K |
|
307
Cooper Companies
COO
$13.7B
| $298K | 0.01% |
4,186
-27
| -0.6% | -$2.07K |
|
308
Zimmer Biomet
ZBH
$17.7B
| $298K | 0.01% |
3,265
-29
| -0.9% | -$2.8K |
|
309
Credo Technology Group
CRDO
$39.7B
| $295K | 0.01% |
+3,185
| New | +$186K |
|
310
Baxter International
BAX
$11.6B
| $294K | 0.01% |
9,723
-148
| -1% | -$4.49K |
|
311
West Pharmaceutical
WST
$23.1B
| $294K | 0.01% |
1,343
-135
| -9% | -$28.9K |
|
312
Crinetics Pharmaceuticals
CRNX
$8.86B
| $291K | 0.01% |
10,131
+586
| +6% | +$18.1K |
|
313
ConocoPhillips
COP
$147B
| $290K | 0.01% |
3,232
-99
| -3% | -$8.91K |
|
314
Viatris
VTRS
$20.1B
| $288K | 0.01% |
32,239
-2,464
| -7% | -$20.8K |
|
315
Charles River Laboratories
CRL
$10.9B
| $284K | 0.01% |
1,874
+21
| +1% | +$2.8K |
|
316
DaVita
DVA
$15.1B
| $284K | 0.01% |
1,995
-155
| -7% | -$22K |
|
317
Bio-Techne
TECH
$11.2B
| $283K | 0.01% |
5,497
+235
| +4% | +$11.8K |
|
318
Sarepta Therapeutics
SRPT
$1.66B
| $283K | 0.01% |
16,525
+7,416
| +81% | +$316K |
|
319
Blackstone
BX
$104B
| $281K | 0.01% |
1,879
| – | – |
|
320
Robinhood
HOOD
$85.2B
| $281K | 0.01% |
+3,001
| New | +$178K |
|
321
Zebra Technologies
ZBRA
$12.4B
| $279K | 0.01% |
906
-155
| -15% | -$42.1K |
|
322
Chubb
CB
$140B
| $279K | 0.01% |
964
| – | – |
|
|
APLS
323
DELISTED
Apellis Pharmaceuticals
APLS
| $278K | 0.01% |
16,057
-778
| -5% | -$14.4K |
|
|
MRSH
324
Marsh
MRSH
$86.3B
| $273K | 0.01% |
1,248
-15
| -1% | -$3.39K |
|
325
Intercontinental Exchange
ICE
$82.4B
| $265K | 0.01% |
1,447
-53
| -4% | -$9.11K |
|
Similar funds
VFCM
DFO
DIA
5NCM
TAM
CS
OAM
QCG
E Fund Management's Q2 2025 Portfolio in Review
As of Q2 2025, E Fund Management held 429 positions worth $2.1B, up 0.21% from $2.09B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
E Fund Management withdrew a net $179M in Q2 2025, closing 35 positions and reducing 267 holdings. Its most notable exit was KE Holdings, an estimated $70.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, E Fund Management opened a new position in Invesco DB Oil Fund worth $11M.
- E Fund Management's largest Q2 2025 buy was Invesco DB Oil Fund: 835,473 shares worth $11M.
- E Fund Management added most to abrdn Physical Gold Shares ETF in Q2 2025, an estimated $19.9M increase.
- E Fund Management's biggest Q2 2025 reduction was Futu Holdings, cutting an estimated $30.9M.
- E Fund Management fully exited KE Holdings in Q2 2025, selling an estimated $70.4M.
- E Fund Management's ten largest holdings make up 52% of its $2.1B portfolio in Q2 2025.
- E Fund Management opened 31 new positions and closed 35 in Q2 2025.
- E Fund Management's portfolio value rose 0.21% quarter-over-quarter to $2.1B.
Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.